The DOI matches its Crossref record; 42 of the 44 references it cites were found in a registry or an index.
Depression-like behaviour in rats with mononeuropathy is reduced by the CB2-selective agonist GW405833
Abstract
The current study assessed whether the chronic constriction injury (CCI) model of neuropathic pain causes depression-like behaviour in animals, and if this depression-like behaviour can be reversed by anti-nociceptive and/or antidepressant drugs. CCI of the sciatic nerve in rats was selected as a neuropathic pain model, mechanical hypersensitivity was assessed by punctuate mechanical stimuli, and depression-like behaviour was evaluated in the forced swimming test (FST) measuring the time of immobility, climbing and swimming. The CCI rats displayed a significant mechanical hypersensitivity (sham 27+/-2g, CCI 12+/-2g; P<0.001) and a significant increase in time of immobility (sham 133+/-14s, CCI 201+/-9s; P<0.001). As time of swimming was unchanged, immobility was increased at the expense of climbing behaviour (sham 105+/-17s, CCI 63+/-9s; P<0.05). There was no difference in ambulation between sham and CCI animals. In sham and CCI animals, desipramine (20mg/kg) significantly reduced immobility (sham+vehicle 134+/-19s, sham+desipramine 79+/-13s; P<0.01, CCI+vehicle 195+/-8s, CCI+desipramine 140+/-11s; P<0.05) and increased climbing behaviour (sham+vehicle 118+/-21s, sham+desipramine 182+/-16s; P<0.05, CCI+vehicle 59+/-8s, CCI+desipramine 112+/-14s; P<0.05) with little effect on mechanical hypersensitivity. In contrast in CCI animals the cannabinoid CB2-selective agonist GW405833 (2,3-dichloro-phenyl)-[5-methoxy-2-methyl-3-(2-morpholin-4-yl-ethyl)-indol-1-yl]-methanone) (30 mg/kg) significantly attenuated immobility (CCI+vehicle 191+/-7s, GW405833 145+/-14s; P<0.01) and mechanical hypersensitivity (CCI+vehicle 15+/-1g, CCI+GW405833 24+/-1g; P<0.001). Moreover, differently from desipramine, GW405833 did not change the climbing behaviour. These data suggest that rats subjected to the CCI model of neuropathic pain develop depression-like behaviour, which can be reversed by appropriate anti-nociceptive treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Interestingly, GW405833, a CB2-specific agonist, also reduces depression-like behavior associated with this mononeuropathy in the forced swim test.50”
From Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside (2009) · cites this paper as [50]
Citations
Cites
Ethical guidelines for investigations of experimental pain in conscious animals.
Zimmermann, M. (1983) · Pain · doi:10.1016/0304-3959(83)90201-4 · Cited by 7,762
A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man
Bennett, G. J., & Xie, Y.-K. (1988) · Pain · doi:10.1016/0304-3959(88)90209-6 · Cited by 5,376
Depression and Pain Comorbidity: A Literature Review
Bair, M. J., Robinson, R. L., Katon, W., & Kroenke, K. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.20.2433 · Cited by 3,463
Pharmacologic management of neuropathic pain: Evidence-based recommendations
Dworkin, R. H., O’Connor, A. B., Backonja, M., Farrar, J. T., Finnerup, N. B., Jensen, T. S., Kalso, E. A., Loeser, J. D., Miaskowski, C., Nurmikko, T. J., et al. (2007) · Pain · doi:10.1016/j.pain.2007.08.033 · Cited by 2,126
Assessing antidepressant activity in rodents: recent developments and future needs
Cryan, J. F., Markou, A., & Lucki, I. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02017-5 · Cited by 1,551 · cited 3×
“In the FST, climbing and swimming active behaviours are selectively altered by the noradrenergic and serotonergic systems, respectively [6,7,21].”
BackgroundMethodQuantitative sensory testing: a comprehensive protocol for clinical trials
Rolke, R., Magerl, W., Andrews, K., Schalber, C., Caspari, S. S., Birklein, F., & Treede, R. (2005) · European Journal of Pain · doi:10.1016/j.ejpain.2005.02.003 · Cited by 1,521
Detke, M. J., Rickels, M. R., & Lucki, I. (1995) · Psychopharmacology · doi:10.1007/bf02245592 · Cited by 1,466
From the gate to the neuromatrix
Melzack, R. (1999) · Pain · doi:10.1016/s0304-3959(99)00145-1 · Cited by 1,170
Sindrup, S. H., & Jensen, T. S. (1999) · Pain · doi:10.1016/s0304-3959(99)00154-2 · Cited by 1,142
EFNS guidelines on pharmacological treatment of neuropathic pain
Attal, N., Cruccu, G., Haanpää, M. L., Hansson, P. T., Jensen, T. S., Nurmikko, T. J., Sampaio, C., Sindrup, S. H., & Wiffen, P. J. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01511.x · Cited by 877
Cited by
Sorted by citations
The endocannabinoid system and the brain.
Mechoulam, R., & Parker, L. A. (2013) · Annual Review of Psychology · doi:10.1146/annurev-psych-113011-143739 · Cited by 1,090
Factors influencing behavior in the forced swim test
Bogdanova, O. V., Kanekar, S., D’Anci, K. E., & Renshaw, P. F. (2013) · Physiology & Behavior · doi:10.1016/j.physbeh.2013.05.012 · Cited by 494
Is lipid signaling through cannabinoid 2 receptors part of a protective system?
Pacher, P., & Mechoulam, R. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.01.001 · Cited by 435
Modulating the endocannabinoid system in human health and disease – successes and failures
Pacher, P., & Kunos, G. (2013) · FEBS Journal · doi:10.1111/febs.12260 · Cited by 418
Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside
Rahn, E. J., & Hohmann, A. G. (2009) · Neurotherapeutics · doi:10.1016/j.nurt.2009.08.002 · Cited by 305
Donvito, G., Nass, S. R., Wilkerson, J. L., Curry, Z. A., Schurman, L. D., Kinsey, S. G., & Lichtman, A. H. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.204 · Cited by 301
Neuroplasticity Underlying the Comorbidity of Pain and Depression
Doan, L., Manders, T. R., & Wang, J. (2015) · Neural Plasticity · doi:10.1155/2015/504691 · Cited by 304
Activation of Corticostriatal Circuitry Relieves Chronic Neuropathic Pain
Lee, M., Manders, T. R., Eberle, S. E., Su, C. H., D’amour, J. A., Yang, R., Lin, H. Y., Deisseroth, K. A., Froemke, R. C., & Wang, J. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.3494-14.2015 · Cited by 261
Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies
Finn, D. P., Haroutounian, S., Hohmann, A. G., Krane, E. J., Soliman, N., & Rice, A. S. C. (2021) · Pain · doi:10.1097/j.pain.0000000000002268 · Cited by 280
Endocannabinoid system and mood disorders: Priming a target for new therapies
Micale, V., Marzo, V. D., Šulcová, A., Wotjak, C. T., & Drago, F. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.12.002 · Cited by 224
Improving the translation of analgesic drugs to the clinic: animal models of neuropathic pain
du Sert, N. P., & Rice, A. S. C. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12645 · Cited by 195
Urban, R., Scherrer, G., Goulding, E. H., Tecott, L. H., & Basbaum, A. I. (2011) · Pain · doi:10.1016/j.pain.2010.12.003 · Cited by 189
Chronic Pain Leads to Concomitant Noradrenergic Impairment and Mood Disorders
Alba‐Delgado, C., Llorca-Torralba, M., Horrillo, I., Ortega, J. E., Micó, J. A., Sánchez‐Blázquez, P., Meana, J. J., & Berrocoso, E. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.06.033 · Cited by 182
Pain and depression comorbidity: A preclinical perspective
Li, J. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.04.042 · Cited by 175
How to study anxiety and depression in rodent models of chronic pain?
Kremer, M., Becker, L. J., Barrot, M., & Yalçın, İ. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14686 · Cited by 176
The molecular neurobiology of chronic pain–induced depression
Humo, M., Lu, H., & Yalçın, İ. (2019) · Cell and Tissue Research · doi:10.1007/s00441-019-03003-z · Cited by 167
Chronic Constriction of the Sciatic Nerve and Pain Hypersensitivity Testing in Rats
Austin, P. J., Wu, A., & Moalem‐Taylor, G. (2012) · Journal of Visualized Experiments · doi:10.3791/3393 · Cited by 154
Navarro, G., Morales, P., Rodríguez‐Cueto, C., Fernández‐Ruíz, J., Jagerovic, N., & Franco, R. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00406 · Cited by 150
Goffer, Y., Xu, D., Eberle, S. E., D’amour, J. A., Lee, M., Tukey, D. S., Froemke, R. C., Ziff, E. B., & Wang, J. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2454-13.2013 · Cited by 147
Endocannabinoid System Components as Potential Biomarkers in Psychiatry
Navarrete, F., García‐Gutiérrez, M. S., Barba, R. J., Rubio, G., Gasparyan, A., Austrich-Olivares, A., & Manzanares, J. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.00315 · Cited by 146
The endocannabinoid system and neuropathic pain
Maldonado, R. J., Baños, J.-E., & Cabañero, D. (2015) · Pain · doi:10.1097/j.pain.0000000000000428 · Cited by 131
Gorzalka, B. B., & Hill, M. N. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.11.021 · Cited by 120
Inflammatory and Neuropathic Pain From Bench to Bedside: What Went Wrong?
Yezierski, R. P., & Hansson, P. T. (2018) · Journal of Pain · doi:10.1016/j.jpain.2017.12.261 · Cited by 115
Role of Cannabinoids in the Treatment of Pain and (Painful) Spasticity
Karst, M., Wippermann, S., & Ahrens, J. (2010) · Drugs · doi:10.2165/11585260-000000000-00000 · Cited by 91
Brain CB2 Receptors: Implications for Neuropsychiatric Disorders
Roche, M., & Finn, D. P. (2010) · Pharmaceuticals · doi:10.3390/ph3082517 · Cited by 88
Caspani, O., Reitz, M.-C., Ceci, A., Kremer, A., & Treede, R. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.06.018 · Cited by 80
Li, Q., Yue, N., Liu, S., Wang, Z., Mi, W., Jiang, J., Wu, G.-C., Yu, J. M., & Wang, Y.-Q. (2014) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2014/158987 · Cited by 79
Distinct roles of neuronal and microglial CB2 cannabinoid receptors in the mouse hippocampus
Li, Y., & Kim, J. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.08.053 · Cited by 78
Niu, L., Hou, Y., Jiang, M., & Bai, G. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114524 · Cited by 79
“Bedside-to-Bench” Behavioral Outcomes in Animal Models of Pain: Beyond the Evaluation of Reflexes
Cobos, E. J., & Portillo-Salido, E. F. (2013) · Current Neuropharmacology · doi:10.2174/1570159x113119990041 · Cited by 78
The CGRP receptor antagonist BIBN4096BS peripherally alleviates inflammatory pain in rats
Hirsch, S. J., Corradini, L., Just, S., Arndt, K., & Doods, H. N. (2013) · Pain · doi:10.1016/j.pain.2013.01.002 · Cited by 74
Cannabinoid CB2 receptor‐mediated regulation of impulsive‐like behaviour in DBA/2 mice
Navarrete, F., Pérez‐Ortiz, J. M., & Manzanares, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01542.x · Cited by 72
Zhao, X., Wang, C., Zhang, J., Liu, L., Liu, A., Ma, Q., Zhou, W., & Xu, Y. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3368-2 · Cited by 71
Burke, N. N., Geoghegan, E. M., Kerr, D. M., Moriarty, O., Finn, D. P., & Roche, M. (2013) · Genes Brain & Behavior · doi:10.1111/gbb.12080 · Cited by 71
The amygdala, a relay station for switching on and off pain
Rouwette, T., Vanelderen, P., Roubos, E. W., Kozicz, T., & Vissers, K. C. P. (2011) · European Journal of Pain · doi:10.1002/j.1532-2149.2011.00071.x · Cited by 70
Antidepressant-like effects of β-caryophyllene on restraint plus stress-induced depression
Hwang, E., Kim, H.-B., Lee, S., Kim, M. J., Kim, K.-J., Han, G., Han, S.-Y., Lee, E.-A., Yoon, J.-H., Kim, D., et al. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112439 · Cited by 69
Burke, N. N., Hayes, E., Calpin, P., Kerr, D. M., Moriarty, O., Finn, D. P., & Roche, M. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.10.030 · Cited by 66
Kruk-Słomka, M., Michalak, A., & Biała, G. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.01.051 · Cited by 64
New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders
Kibret, B. G., Ishiguro, H., Horiuchi, Y., & Onaivi, E. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020975 · Cited by 69
Latest Advances in Novel Cannabinoid Cb2Ligands for Drug Abuse and Their Therapeutic Potential
Yang, P., Wang, L., & Xie, X.-Q. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.11.179 · Cited by 58
Nettekoven, M. H., Adam, J., Bendels, S., Bissantz, C., Fingerle, J., Grether, U., Grüner, S., Guba, W., Kimbara, A., Ottaviani, G., et al. (2015) · ChemMedChem · doi:10.1002/cmdc.201500218 · Cited by 58
Jessé, C. R., Wilhelm, E. A., & Nogueira, C. W. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1977-6 · Cited by 61
Malvestio, R. B., de Medeiros, P. S., Negrini-Ferrari, S. E., Oliveira-Silva, M., Medeiros, A. C., Padovan, C. M., Luongo, L., Maione, S., Coimbra, N. C., & de Freitas, R. L. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.06.017 · Cited by 60
Brownjohn, P. W., & Ashton, J. C. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.12.028 · Cited by 57
High Times for Painful Blues: The Endocannabinoid System in Pain-Depression Comorbidity
Fitzgibbon, M., Finn, D. P., & Roche, M. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv095 · Cited by 60
Evens, N., Vandeputte, C., Muccioli, G. G., Lambert, D. M., Baekelandt, V., Verbruggen, A., Debyser, Z., Laere, K. V., & Bormans, G. M. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.06.033 · Cited by 56
Liu, L., Li, Q., Sapolsky, R. M., Liao, M., Mehta, K. R., Bhargava, A., & Pasricha, P. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019498 · Cited by 56
Cannabinoids in depressive disorders
Poleszak, E., Wośko, S., Sławińska, K., Szopa, A., Wróbel, A., & Serefko, A. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.09.058 · Cited by 56
Animal Models for the Study of Comorbid Pain and Psychiatric Disorders
Leite‐Almeida, H., Pinto‐Ribeiro, F., & Almeida, A. (2015) · Modern trends in psychiatry · doi:10.1159/000435929 · Cited by 56
de Medeiros, P. S., dos Santos, I. R., Júnior, I. M., Palazzo, E., Silva, J. A. D., Machado, H. R., Ferreira, S. H., Maione, S., Coimbra, N. C., & de Freitas, R. L. (2020) · Pain Medicine · doi:10.1093/pm/pnaa206 · Cited by 53
The central cannabinoid receptor type-2 (CB2) and chronic pain
Shang, Y.-C., & Tang, Y. (2016) · International Journal of Neuroscience · doi:10.1080/00207454.2016.1257992 · Cited by 51
Hossain, M. Z., Ando, H., Unno, S., & Kitagawa, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041423 · Cited by 54
Nagakura, Y., Takahashi, M., Noto, T., Sekizawa, T., Oe, T., Yoshimi, E., Tamaki, K., & Shimizu, Y. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.09.023 · Cited by 51
Persistent pain alters AMPA receptor subunit levels in the nucleus accumbens
Su, C. H., D’amour, J. A., Lee, M. S., Lin, H.-Y., Manders, T. R., Xu, D., Eberle, S. E., Goffer, Y., Zou, A., Rahman, M., et al. (2015) · Molecular Brain · doi:10.1186/s13041-015-0140-z · Cited by 52
Fonseca‐Rodrigues, D., Amorim, D., Almeida, A., & Pinto‐Ribeiro, F. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.113008 · Cited by 47
Experimental neuropathy increases limbic forebrain CRF
Rouwette, T., Vanelderen, P., de Reus, M., Loohuis, N. F. M. O., Giele, J. L. P., van Egmond, J., Scheenen, W. J. J. M., Scheffer, G. J., Roubos, E. W., Vissers, K. C. P., et al. (2011) · European Journal of Pain · doi:10.1016/j.ejpain.2011.05.016 · Cited by 49
Role of the Endocannabinoid System in Depression: from Preclinical to Clinical Evidence
Micale, V., Tabiová, K., Kučerová, J., & Drago, F. (2015) · Springer eBooks · doi:10.1007/978-1-4939-2294-9_5 · Cited by 47
Liu, P., Chen, J., Ma, S., Zhang, J., & Zhou, J. (2020) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa076 · Cited by 46
Alba‐Delgado, C., Cebada-Aleu, A., Micó, J. A., & Berrocoso, E. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.06.007 · Cited by 50
Zhao, X., Wang, C., Cui, W., Ma, Q., & Zhou, W. (2015) · Scientific Reports · doi:10.1038/srep09043 · Cited by 43
Ketamine-induced antidepressant like effects in mice: A possible involvement of cannabinoid system
Khakpai, F., Ebrahimi-Ghiri, M., Alijanpour, S., & Zarrindast, M. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.108717 · Cited by 44
Molecular Alterations of the Endocannabinoid System in Psychiatric Disorders
Navarro, D., Gasparyan, A., Navarrete, F., Torregrosa, A. B., Rubio, G., Marín, M., Acosta, G. B., García‐Gutiérrez, M. S., & Manzanares, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094764 · Cited by 47
Modulation of Endocannabinoid System Components in Depression: Pre-Clinical and Clinical Evidence
Bright, U., & Akirav, I. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105526 · Cited by 48
Microglial Cannabinoid CB2 Receptors in Pain Modulation
Xu, K., Wu, Y., Tian, Z., Xu, Y., Wu, C., & Wang, Z. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032348 · Cited by 43
Li, Q., Liu, S., Zhu, X., Mi, W., Mao‐Ying, Q., Wang, J., Yu, J. M., & Wang, Y.-Q. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.05.025 · Cited by 40
Moriarty, O., Roche, M., McGuire, B. E., & Finn, D. P. (2011) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2011.10.024 · Cited by 40
Li, A.-L., Carey, L. M., Mackie, K., & Hohmann, A. G. (2017) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.241901 · Cited by 39
The Endocannabinoid/Endovanilloid System and Depression
Smaga, I., Bystrowska, B., Gawliński, D., Przegaliński, E., & Filip, M. (2014) · Current Neuropharmacology · doi:10.2174/1570159x12666140923205412 · Cited by 40
Pain in neuropsychiatry: Insights from animal models
Bravo, L., Llorca-Torralba, M., Suárez‐Pereira, I., & Berrocoso, E. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.04.029 · Cited by 41
Haj‐Mirzaian, A., Amini-Khoei, H., Haj‐Mirzaian, A., Amiri, S., Ghesmati, M., Zahir, M., Shafaroodi, H., & Dehpour, A. R. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.01.018 · Cited by 38
Chronic pain impact on rodents’ behavioral repertoire
Cunha, A. M., Pereira-Mendes, J., Almeida, A., Guimarães, M. R., & Leite‐Almeida, H. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.09.022 · Cited by 38
Mlost, J., Wąsik, A., & Starowicz, K. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.02.029 · Cited by 38
Jiang, H., Ke, B., Liu, J., Ma, G., Hai, K., Gong, D., Yang, Z., & Zhou, C. (2018) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000003563 · Cited by 35
Gould, S. A., Doods, H. N., Lamla, T., & Pekcec, A. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.12.019 · Cited by 33
Role of hypothalamic cannabinoid receptors in post-stroke depression in rats
Wang, S., Sun, H., Liu, S., Wang, T., Guan, J.-Q., & Jia, J. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.01.006 · Cited by 33
Hu, B., Doods, H. N., Treede, R., & Ceci, A. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.03.019 · Cited by 32
Towards a Personalized Treatment in Depression: Endocannabinoids, Inflammation and Stress Response
Zajkowska, Z., Englund, A., & Zunszain, P. A. (2014) · Pharmacogenomics · doi:10.2217/pgs.14.40 · Cited by 30
Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders
Ishiguro, H., Kibret, B. G., Horiuchi, Y., & Onaivi, E. S. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.828895 · Cited by 29
Are CB2 Receptors a New Target for Schizophrenia Treatment?
Cortez, I. L., da Silva, N. R., Guimarães, F. S., & Gomes, F. V. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2020.587154 · Cited by 29
Meanti, R., Bresciani, E., Rizzi, L., Molteni, L., Coco, S., Omeljaniuk, R. J., & Torsello, A. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118044 · Cited by 30
Leitl, M. D., & Negus, S. S. (2015) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000207 · Cited by 28
The CB2 cannabinoid receptor as a therapeutic target in the central nervous system
Cabañero, D., Martín‐García, E., & Maldonado, R. J. (2021) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2021.1971196 · Cited by 30
Amorim, D., Puga, S., Bragança, R., Braga, A., Pertovaara, A., Almeida, A., & Pinto‐Ribeiro, F. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.03.003 · Cited by 26
Neuropathic pain increases spontaneous and noxious-evoked activity of locus coeruleus neurons
Alba‐Delgado, C., Micó, J. A., & Berrocoso, E. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110121 · Cited by 26
Rutten, K., Gould, S. A., Bryden, L. A., Doods, H. N., Christoph, T., & Pekcec, A. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.04.049 · Cited by 26
CB2 Receptor Involvement in the Treatment of Substance Use Disorders
Navarrete, F., García‐Gutiérrez, M. S., Gasparyan, A., Navarro, D., & Manzanares, J. (2021) · Biomolecules · doi:10.3390/biom11111556 · Cited by 27
AMPAkines Target the Nucleus Accumbens to Relieve Postoperative Pain
Su, C. H., Lin, H. Y., Yang, R., Xu, D., Lee, M., Pawlak, N., Norcini, M., Sideris, A., Recio‐Pinto, E., Huang, D., et al. (2016) · Anesthesiology · doi:10.1097/aln.0000000000001336 · Cited by 25
Kalman, E., & Keay, K. A. (2014) · Journal of Anatomy · doi:10.1111/joa.12238 · Cited by 23
Alba‐Delgado, C., Llorca-Torralba, M., Micó, J. A., & Berrocoso, E. (2018) · Pain · doi:10.1097/j.pain.0000000000001372 · Cited by 20
Wilkerson, J. L., & Milligan, E. D. (2011) · ISRN Anesthesiology · doi:10.5402/2011/593894 · Cited by 20
Yu, C., Zhang, Y., Gao, K.-X., Sun, H.-T., Gong, M., Zhao, X., & Ren, P. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173184 · Cited by 19
Common Pathways for Pain and Depression-Implications for Practice
Mihăilescu-Marin, M.-M., Mosoiu, D. V., Burtea, V., Sechel, G., Rogozea, L. M., & Ciurescu, D. (2020) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000001235 · Cited by 19
Integrating Endocannabinoid Signalling In Depression
Rana, T., Behl, T., Sehgal, A., Mehta, V., Singh, S., Kumar, R., & BUNGAU, S. G. (2021) · Journal of Molecular Neuroscience · doi:10.1007/s12031-020-01774-7 · Cited by 20
Murad, H. A. S. (2015) · Pain Physician · doi:10.36076/ppj.2015/18/609 · Cited by 17
Poleszak, E., Wośko, S., Sławińska, K., Wyska, E., Szopa, A., Sobczyński, J., Wróbel, A., Doboszewska, U., Właź, P., Właź, A., et al. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112297 · Cited by 17
Alendronate Attenuates Spinal Microglial Activation and Neuropathic Pain
Yao, Y., Tan, Y.-H., Light, A. R., Mao, J., Yu, A. C., & Fu, K. (2016) · Journal of Pain · doi:10.1016/j.jpain.2016.03.008 · Cited by 17
Sexual dimorphism in cognitive disorders in a murine model of neuropathic pain
Won, S., Park, K., Lim, H., & Lee, S. J. (2020) · Behavioral and Brain Functions · doi:10.1186/s12993-019-0164-0 · Cited by 15
Long, H., Chen, Z., Xu, X., Zhou, Q., Fang, Z., Lv, M., Yang, X.-H., Xiao, J., Sun, H., & Fan, M. (2024) · NeuroImage · doi:10.1016/j.neuroimage.2024.120722 · Cited by 15
Nettekoven, M. H., Fingerle, J., Grether, U., Grüner, S., Kimbara, A., Püllmann, B., Rogers‐Evans, M., Röver, S., Schuler, F., Schulz‐Gasch, T., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.01.044 · Cited by 14
Boullon, L., Finn, D. P., & Llorente‐Berzal, A. (2024) · Journal of Pain · doi:10.1016/j.jpain.2024.104752 · Cited by 13
Metadata
- Authors
- Hu, B., Doods, H., Treede, R.-D., & Ceci, A.
- Affiliations
- Boehringer Ingelheim (Germany) (DE)
- Heidelberg University (DE)
- Corresponding author
- Ceci, Angelo
- Venue
- Pain
- Published
- 2009-06
- Volume
- 143
- Issue
- 3
- Pages
- 206-212
- ISSN
- 0304-3959 (ISSN-L)
- OpenAlex
- W2001545679
- Cited by
- 138
- References
- 44
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 3 · 2023: 4 · 2022: 5 · 2021: 11 · 2020: 17 · 2019: 8 · 2018: 6 · 2017: 6 · 2016: 8 · 2015: 15 · 2014: 9 · 2013: 11 · 2012: 6
- FWCI
- 5.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Pain (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Bundesministerium für Bildung und Forschung
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- CB2 receptor agonist, neuropathic pain, depression-like behavior, chronic constriction injury, sciatic nerve, forced swim test, immobility, desipramine, mechanical hypersensitivity, cannabinoid therapy, antidepressant effects, nociception, rats, pain-depression comorbidity, neuroinflammation, neuroprotection, neurogenesis, neuroplasticity
- MeSH terms
- Animals, Antidepressive Agents, Antidepressive Agents, Tricyclic, Behavior, Animal, Depressive Disorder, Desipramine, Disease Models, Animal, Exploratory Behavior, Hyperalgesia, Indoles, Ligation, Male, Morpholines, Motor Activity, Neuralgia, Neuropsychological Tests, Pain Measurement, Peripheral Nervous System Diseases, Swimming, Treatment Outcome, Rats, Wistar, Sciatic Neuropathy, Receptor, Cannabinoid, CB2, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
